Vivelle-Dot vs. Provera

See how Vivelle-Dot and Provera compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Vivelle-Dot is an estrogen patch for hot flashes and vaginal dryness, while Provera is an oral progestin used for abnormal bleeding or to protect the uterus during estrogen therapy.

  • Women with a uterus who use Vivelle-Dot typically need a progestin such as Provera added to lower the risk of endometrial cancer from unopposed estrogen.

  • Vivelle-Dot is changed on the skin twice a week, while Provera is taken by mouth only for short, defined courses of 5 to 10 days.

Vivelle-Dot vs. Provera Drug Summary

Vivelle-Dot

Vivelle-Dot is an estrogen (estradiol) patch used to treat moderate to severe hot flashes and vaginal dryness caused by menopause, and to help prevent bone loss after menopause. The patch is worn on the skin and replaced twice weekly, delivering a steady dose of hormone without a daily pill.

Provera

Provera is a progestin (synthetic progesterone) tablet used to bring on a period in women with secondary amenorrhea and to treat abnormal uterine bleeding from hormone imbalance. It is taken by mouth in short courses of 5 to 10 days, or added to daily estrogen to protect the uterine lining.

Vivelle-Dot vs. Provera Side Effects

Vivelle-Dot

Most common
Nasopharyngitis (up to 20%)
URI (up to 17%)
Sinusitis (up to 13%)
Sinus headache (up to 11%)

Provera

Most common
Abnormal bleeding (rate n/a)
Breast tenderness (rate n/a)
Nausea (rate n/a)
Headache (rate n/a)

Vivelle-Dot vs. Provera Dosage

Vivelle-Dot

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.0375 mg/day patch At the start
Maximum dose 0.025-0.1 mg/day patch If needed
Dose changes 2 increases As tolerated

Provera

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg or 10 mg daily At the start
Maximum dose 10 mg daily If needed
Dose changes 1 increase As tolerated

Vivelle-Dot vs. Provera Indications

Vivelle-Dot

Vivelle-Dot delivers estradiol through a patch worn on the skin to relieve moderate to severe hot flashes, night sweats, and vaginal dryness that come with menopause. It is also approved to help prevent bone loss in postmenopausal women at risk for osteoporosis.

  • Moderate to severe hot flashes from menopause

  • Vaginal dryness and vulvar/vaginal atrophy

  • Low estrogen from ovarian failure or removal

Provera

Provera delivers medroxyprogesterone acetate by mouth to bring on a period in women with secondary amenorrhea and to treat abnormal uterine bleeding caused by hormone imbalance. It is also prescribed alongside daily conjugated estrogen to protect the uterine lining in women who still have a uterus.

  • Secondary amenorrhea (absent periods)

  • Abnormal uterine bleeding from hormone imbalance

  • Endometrial protection with conjugated estrogen

Vivelle-Dot vs. Provera Pros and Cons

Vivelle-Dot

Vivelle-Dot delivers estrogen through the skin, avoiding the liver's first pass and potentially lowering clotting risk compared with oral estrogen pills. Coverage varies by plan, and many insurers favor the lower-cost generic estradiol patch over the brand name.

Pros

  • Twice-weekly patch avoids daily pills

  • Five dose strengths allow fine-tuned titration

  • Transdermal route may carry lower clot risk than oral estrogen

  • Stays on through showering, swimming, and exercise

Cons

  • Must add a progestin if the uterus is still present

  • Contraindicated with history of clots, stroke, or heart attack

  • Brand-name cost runs roughly $150 to $450 a month without insurance

  • Possible skin irritation at the patch site

Provera

Provera is an inexpensive, well-established progestin used in short, defined courses rather than continuous daily therapy. It carries the same class-wide boxed warning as other progestins when combined with estrogen, and it does not treat hot flashes or vaginal dryness on its own.

Pros

  • Roughly $15 to $75 a month, far less than brand-name Vivelle-Dot

  • Short 5- to 10-day courses instead of continuous daily use

  • Protects the uterine lining when added to estrogen therapy

  • Long track record since FDA approval in 1959

Cons

  • Shares the same boxed warning risks when combined with estrogen

  • Requires daily oral dosing during each treatment course

  • Does not relieve hot flashes or vaginal dryness on its own

  • Contraindicated in liver disease or hormone-sensitive cancers

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.